Finance Home - My Yahoo - Yahoo! - Help

Monday, November 30, 2009, 2:04AM ET - U.S. Markets open in 7 hours and 26 minutes. Dow  1.48% Nasdaq  1.73%

Repligen Corporation (RGEN)

On Nov 27: 4.65   0.07 (1.48%)

MORE ON RGEN

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Industry: Biotechnology Get Industry for:
RGEN SECTOR / INDUSTRY MEMBERSHIP Sector: Healthcare Industry: Biotechnology INTRADAY PERFORMANCE SUMMARY Name Ticker Change Repligen Corporation RGEN 1.48% Biotechnology ^YHOh788 1.21% View Biotechnology Industry Center BIOTECHNOLOGY INDUSTRY NEWS • New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents Mon 1:30 AM - PR Newswire • Soft-talking revolutionary Sun 5:50 PM - at FT.com • Less Toxic Monoclonal Antibodies And Increased Patent Protection For Biologics Creates Multiple Positive Investment Scenarios In Biotechnology Sector Sat 10:23 AM - Wall Street Transcript • Theravance says FDA delays new Vitabiv decision Fri 2:45 PM - AP • Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia Fri 1:30 PM - Marketwire More Industry News... TOP BIOTECHNOLOGY COMPANIES BY MARKET CAP Company Symbol Price Change Market Cap P/E Amgen Inc. AMGN 56.50 1.02% 57.19B 12.32 Gilead Sciences Inc. GILD 46.56 0.89% 41.90B 18.00 Celgene Corporation CELG 54.97 1.40% 25.26B 68.54 Biogen Idec Inc. BIIB 46.92 1.12% 13.57B 15.70 Genzyme Corp. GENZ 51.07 0.87% 13.55B 29.12 Repligen Corporation RGEN 4.65 1.48% 143.02M N/A Showing 1 - 5 of 199 - View All More Top Companies: by Performance, by Valuation, by Growth, more... RGEN VS. INDUSTRY LEADERS Statistic Industry Leader RGEN RGEN Rank Market Capitalization AMGN 57.19B 143.02M 81 / 199 P/E Ratio (ttm) BMRN 88.49 N/A N/A PEG Ratio (ttm, 5 yr expected) HGSI 186.40 N/A N/A Revenue Growth (Qtrly YoY) OSIR 963.70% 6.50% 61 / 199 EPS Growth (Qtrly YoY) SSRX 1349.60% N/A N/A Long-Term Growth Rate (5 yr) AMLN 62% N/A N/A Return on Equity (ttm) INSM 184.07% -6.78% 37 / 199 Long-Term Debt/Equity (mrq) N/A Dividend Yield (annual) PDLI 15.10% N/A N/A View Leaders & Laggards MORE ON BIOTECHNOLOGY • Industry Summary • News • Leaders & Laggards • Company List • Industry Calendar RELATED INDUSTRIES • Diagnostic Substances • Drug Delivery • Drug Manufacturers - Major • Drug Manufacturers - Other • Drug Related Products • Drugs - Generic Top Performing Industries | Complete Industry List
Add to Portfolio     Set Alert     Email to a Friend Get Industry for Another Symbol: Symbol Lookup • Research Reports Screener • Industry Center